FDA WOULD PUBLISH UPDATES ON PHASE IV STUDIES USING REPORTS FROM SPONSORS UNDER LATEST VERSION OF S 830; FLOOR CONSIDERATION DELAYED UNTIL AFTER AUGUST RECESS
Executive Summary
FDA would publish updates annually on specific Phase IV commitments under the latest version of the Senate FDA reform bill (S 830).